NMT Monitoring Services
Details
Incomplete recovery from paralysis at the time of extubation is a patient safety risk.
Every year millions of patients are affected by postoperative respiratory complications. In US alone, more than 100.000 patients annually are at risk of adverse events associated with undetected residual neuromuscular blockade. Clinical studies show that residual neuromuscular block at the end of anesthesia increases the incidence of critical respiratory events. The currently accepted definition for “adequate recovery” from neuromuscular block is the return of the train-of-four (TOF) ratio to, or above 0.9 (90%). It has been shown that this level of recovery restores the most of the functional integrity of the muscles involved in airway protection, but even at this level of recovery, the normal response to hypercarbia (carbon dioxide retention) is blunted. The basic principle for preventing residual neuromuscular block is quantitative neuromuscular monitoring.
Why Monitor Neuromuscular Blockade?
When NMT monitoring is absent, inadequate, or inaccurate, there is an increased risk of:
- pulmonary aspiration
- airway obstruction
- adverse respiratory events (hypoxia, atelectatis, pneumonia, etc)
- pharyngeal dysfunction
- prolonged post anesthesia stays
- unpleasant postoperative symptoms including muscle weakness
Monitoring the effects of neuromuscular blocking drugs ensures their appropriate intra-operative use and helps prevent residual neuromuscular weakness.
Customer reviews
No reviews were found for NMT Monitoring Services. Be the first to review!